BYND Cannasoft Enterprises Inc. (BCAN)

ASHKELON, ISRAEL AND VANCOUVER, BRITISH COLUMBIA – TheNewswire - FEBRUARY 26, 2025 -   Femto Technologies Inc. (Nasdaq: BCAN ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera , a feminine wellness product, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $17 million of Common Shares (also known as Subordinate Voting Shares under British Columbia securities law) and pre-funded and investor warrants at a price of $4.17 per Common Unit. The offering consisted of the sale of Common Units (or Pre-Funded Units), each consisting of (i) one (1) Common Share or Pre-Funded Warrant, (ii) 1 Series A Warrants to purchase one (1) Common Share per warrant and (iii) 1 Series B PIPE Common Warrants to purchase one (1) Common Share per warrant. The offering price per Common Unit is $4.17 (or $4.16999 for each Pre-Funded Unit, which is equal to the offering price per Common Unit sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Unit sold in the offering, the number of Common Units in the offering will be decreased on a one-for-one basis. The initial exercise price of each Series A Common Warrant is $5.21 per Common Share. The Series A Common Warrants are exercisable immediately and expire 60 months after the initial issuance date. The number of securities issuable under the Series A Common Warrant is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.  The initial exercise price of each Series B Common Warrant is $12.51 per Common Share or pursuant to an alternative cashless exercise option. The Series B Common Warrants are exercisable immediately and expire 30 months after the initial issuance date. The number of securities issuable under the Series B Common Warrant is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.

February 6, 2025 – TheNewswire - Vancouver, British Columbia – Impact Acquisition Corp. (TSXV: IMPC.P) (“ Impact ”, the “ Company ” or the “ Resulting Issuer ”) is pleased to announce that further to its press release on January 3, 2025, the Company, Jeffs' Brands Ltd, a corporation incorporated under the laws of the State of Israel and listed on the NASDAQ under the trading symbol “JFBR” (“ Jeffs Brands ” or “ JFBR ”), and Jeffs Brands' wholly owned subsidiary, Fort Products Limited (the “ Target ” or “ Fort Products ”) has entered into a definitive agreement dated February 6, 2025 (the “ Definitive Agreement ”), in respect of an arm's length share sale transaction involving the Target Shares (as defined below) (the “ Proposed Transaction ”), which will result in the reverse takeover of the Company by Jeffs Brands. The Proposed Transaction is expected to constitute the Company's “Qualifying Transaction” as such term is defined in policies of the TSX Venture Exchange (the “ Exchange ”). The Proposed Transaction

Fort Lauderdale, Florida--(Newsfile Corp. - September 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the appointment of Harold Wolkin as an independent director on its Board of Directors. In this role, Mr.

NEW YORK, NY / ACCESSWIRE / March 18, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). About BYND Cannasoft Enterprises Inc. BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel.

Toronto, Ontario--(Newsfile Corp. - Le 14 mars/March 2024) - The common shares of BYND Cannasoft Enterprises Inc. will be delisted from the CSE at market close today, March 14, 2024. The common shares currently trade on Nasdaq.

Israeli Technology Company BYND Cannasoft Enterprises EZ-G Project Team is in Shenzen, China, to solidify agreements with two large manufacturers to produce its EZ-G Device and EZ-G Capsules Israeli Technology Company BYND Cannasoft Enterprises EZ-G Project Team is in Shenzen, China, to solidify agreements with two large manufacturers to produce its EZ-G Device and EZ-G Capsules

NEW YORK, NY / ACCESSWIRE / December 21, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). About BYND Cannasoft Enterprises Inc. BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel.

Israeli Technology Company BYND Cannasoft Enterprises Expands Intellectual Property Portfolio for Its EZ-G Device by filing national phase application for Its EZ-G Device in 11 jurisdictions, including U.S. utility patent application under the Patent Prosecution Highway (PPH) and the European Patent Office (EPO), which includes 38 European countries Israeli Technology Company BYND Cannasoft Enterprises Expands Intellectual Property Portfolio for Its EZ-G Device by filing national phase application for Its EZ-G Device in 11 jurisdictions, including U.S. utility patent application under the Patent Prosecution Highway (PPH) and the European Patent Office (EPO), which includes 38 European countries

ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today on submitting a research and development plan based on a planned budget of US$1.5 million (grant of up to US$0.75 million) to develop CRM software combined with AI for the medical cannabis industry (File number 82745 – Application number 01125047). Israel's Finance Ministry recently clarified its decision to increase the wartime high-tech sector fund to provide short- and long-term measures designed to assist startup companies in Israel's high-tech sector. The Company was found suitable for submitting the application according to the criteria required in the grant program as detailed on the Israel Innovation Authority website.

ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical cannabis in Israel. Recent regulatory reforms approved by the Israeli Ministry of Healthi allows physicians to prescribe cannabis to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical cannabis patientsii in the wake of recent events, particularly the opening of the war in Gaza. This surge has resulted in more than 2,000 new patients in just one month, approaching the peak numbers of 2021 and bringing the total number to over 132,000 as of November 2023. BYND Cannasoft's proprietary Benefit CRM enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset management. Benefit CRM is provisioned as SaaS to some of Israel's most recognizable companies.

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) (“BYND” or the “Company”) has released its financial results for the six-month period ended June 30, 2023. Full versions of BYND's unaudited consolidated interim financial statements and management discussion and analysis for the period can be found on www.sedar.com.

ASHKELON, Israel and VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced that Yftah Ben Yaackov, Chief Executive Officer and Director, shared a comprehensive update on the Company's progress, highlighting significant recent milestones and unveiling promising prospects for the future.

The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023 The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023

ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced several milestones for the second half of 2023 on the development of its groundbreaking EZ-G Device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, could enhance therapeutic approaches for women's health issues by offering cutting-edge technology to cater to the evolving needs of consumers. Moreover, the company is actively negotiating with synergistic businesses, particularly those in the CBD oils sector, for a transformative transaction.

NEW YORK, NY / ACCESSWIRE / July 19, 2023 / Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). About BYND Cannasoft Enterprises Inc. BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel.

ASHKELON, Israel and VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately US$2.6 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consisted of 1,733,334 common shares at a price to the public of US$1.50 per share. The Company intends to use the net proceeds from this offering primarily for product design and manufacturing, sales and marketing campaigns, patent prosecution and working capital.